product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
IMP1 Antibody
catalog :
2852
clonality :
polyclonal
host :
rabbit
conjugate :
nonconjugated
reactivity :
human
application :
western blot, immunocytochemistry
citations: 3
Published Application/Species/Sample/DilutionReference
  • western blot; human; loading ...; fig s9d
Powers J, Tsanov K, Pearson D, Roels F, Spina C, EBRIGHT R, et al. Multiple mechanisms disrupt the let-7 microRNA family in neuroblastoma. Nature. 2016;535:246-51 pubmed publisher
  • immunocytochemistry; human; 1:100; fig 1
  • western blot; human; 1:1000; fig 5
Conway A, Van Nostrand E, Pratt G, Aigner S, Wilbert M, Sundararaman B, et al. Enhanced CLIP Uncovers IMP Protein-RNA Targets in Human Pluripotent Stem Cells Important for Cell Adhesion and Survival. Cell Rep. 2016;15:666-679 pubmed publisher
  • western blot; human; loading ...; fig 6a
Rebucci M, Sermeus A, Leonard E, Delaive E, Dieu M, Fransolet M, et al. miRNA-196b inhibits cell proliferation and induces apoptosis in HepG2 cells by targeting IGF2BP1. Mol Cancer. 2015;14:79 pubmed publisher
product information
SKU :
2852S
Product-Name :
IMP1 Antibody
Size :
100 ul
Price-(USD) :
235 USD
Species-x-Reactivity :
H
Applications :
Western blot
Product-Category :
Translational Control
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Polyclonal Antibody
MW :
64
Host :
Rabbit
Target :
IMP-1
Primary-Protein :
IMP-1
Alt-Names :
CRD-BP,CRDBP,Coding region determinant-binding protein,IF2B1,IGF II mRNA binding protein 1,IGF-II mRNA-binding protein 1,IGF2 mRNA-binding protein 1,IGF2BP1,IMP-1,IMP1,Insulin-like growth factor 2 mRNA-binding protein 1,VICKZ family member 1,VICKZ1,ZBP-1,ZBP1,Zip code-binding protein 1,Zipcode-binding protein 1,insulin-like growth factor 2 mRNA binding protein 1
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.